CNS Stock Summary and Trading Ideas (Cohen & Steers | NYSE:CNS)

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests mainly in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for around two-thirds of its $90.9 billion in managed assets at the end of September 2025. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (26%) of its managed assets (base management fees) from institutional clients, 48% (54%) from open-end funds, and 13% (20%) from closed-end funds.

Cohen & Steers trades on the NYSE stock market under the symbol CNS.

As of March 12, 2026, CNS stock price declined to $62.45 with 254,450 million shares trading.

CNS has a beta of 0.64, meaning it tends to be less sensitive to market movements. CNS has a correlation of 0.17 to the broad based SPY ETF.

CNS has a market cap of $3.18 billion. This is considered a Mid Cap stock.

Last quarter Cohen & Steers reported $144 million in Revenue and $.81 earnings per share. This beat revenue expectation by $626,360 and met earnings estimates .

In the last 3 years, CNS traded as high as $110.67 and as low as $50.05.

The top ETF exchange traded funds that CNS belongs to (by Net Assets): IJR, VTI, SCHD, IWM, VB.

CNS has underperformed the market in the last year with a price return of -19.1% while the SPY ETF gained +21.5%. However, in the short term, CNS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +0.8% vs -2.8% return in SPY. But in the last 2 weeks, CNS shares have been beat by the market, returning -6.6% compared to an SPY return of -3.6%.

CNS support price is $61.53 and resistance is $64.79 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CNS shares will trade within this expected range on the day.